{"version":"1.0","type":"link","title":"Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.","author_name":"Girard N 외","author_url":"https://prs-insight.online/author/Girard%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97683","thumbnail_width":1200,"thumbnail_height":630}